Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters








Database
Language
Publication year range
1.
Redox Biol ; 70: 103070, 2024 04.
Article in English | MEDLINE | ID: mdl-38359745

ABSTRACT

Although widely known as a tumor suppressor, the breast cancer 1 susceptibility protein (BRCA1) is also important in development, where it regulates fetal DNA repair pathways that protect against DNA damage caused by physiological and drug-enhanced levels of reactive oxygen species (ROS). We previously showed that conditional heterozygous (+/-) knockout (cKO) mouse embryos with a minor 28% BRCA1 deficiency developed normally in culture, but when exposed to the ROS-initiating drug, alcohol (ethanol, EtOH), exhibited embryopathies not evident in wild-type (+/+) littermates. Herein, we characterized a directBrca1 +/- knockout (KO) model with a 2-fold greater (58%) reduction in BRCA1 protein vs. the cKO model. We also characterized and compared learning & memory deficits in both the cKO and KO models. Even saline-exposed Brca1 +/- vs. +/+ KO progeny exhibited enhanced oxidative DNA damage and embryopathies in embryo culture and learning & memory deficits in females in vivo, which were not observed in the cKO model, revealing the potential pathogenicity of physiological ROS levels. The embryopathic EtOH concentration for cultured direct KO embryos was half that for cKO embryos, and EtOH affected Brca1 +/+ embryos only in the direct KO model. The spectrum and severity of EtOH embryopathies in culture were greater in both Brca1 +/- vs. +/+ embryos, and direct KO vs. cKO +/- embryos. Motor coordination deficits were evident in both male and female Brca1 +/- KO progeny exposed in utero to EtOH. The results in our direct KO model with a greater BRCA1 deficiency vs. cKO mice provide the first evidence for BRCA1 protein dose-dependent susceptibility to developmental disorders caused by physiological and drug-enhanced oxidative stress.


Subject(s)
Fetal Diseases , Neurodevelopmental Disorders , Humans , Male , Female , Mice , Animals , Ethanol/toxicity , Reactive Oxygen Species/metabolism , BRCA1 Protein/genetics , BRCA1 Protein/metabolism , Embryo, Mammalian/metabolism , Embryo, Mammalian/pathology , Mice, Knockout , Oxidative Stress , DNA Damage , Fetal Diseases/metabolism , Fetal Diseases/pathology , Neurodevelopmental Disorders/chemically induced , Neurodevelopmental Disorders/genetics , Neurodevelopmental Disorders/metabolism , Memory Disorders/genetics , Memory Disorders/metabolism
2.
Free Radic Biol Med ; 208: 272-284, 2023 11 01.
Article in English | MEDLINE | ID: mdl-37541454

ABSTRACT

The breast cancer 1 (Brca1) susceptibility gene regulates the repair of reactive oxygen species (ROS)-mediated DNA damage, which is implicated in neurodevelopmental disorders. Alcohol (ethanol, EtOH) exposure during pregnancy causes fetal alcohol spectrum disorders (FASD), including abnormal brain function, associated with enhanced ROS-initiated DNA damage. Herein, oxidative DNA damage in fetal brains and neurodevelopmental disorders were enhanced in saline-exposed +/- vs. +/+ Brca1 littermates. A single EtOH exposure during gestation further enhanced oxidative DNA damage, altered the expression of developmental/DNA damage response genes in fetal brains, and resulted in neurodevelopmental disorders, all of which were BRCA1-dependent. Pretreatment with the ROS inhibitor phenylbutylnitrone (PBN) blocked DNA damage and some neurodevelopmental disorders in both saline- and EtOH-exposed progeny, corroborating a ROS-dependent mechanism. Fetal BRCA1 protects against altered gene expression and neurodevelopmental disorders caused by both physiological and EtOH-enhanced levels of ROS formation. BRCA1 deficiencies may enhance the risk for FASD.


Subject(s)
Fetal Alcohol Spectrum Disorders , Neoplasms , Neurodevelopmental Disorders , Pregnancy , Humans , Female , Reactive Oxygen Species/metabolism , Ethanol/toxicity , Fetal Alcohol Spectrum Disorders/genetics , Fetal Alcohol Spectrum Disorders/metabolism , Neurodevelopmental Disorders/chemically induced , Neurodevelopmental Disorders/genetics , Gene Expression , BRCA1 Protein/genetics
SELECTION OF CITATIONS
SEARCH DETAIL